We describe an improved "high-pressure" liquid-chromatographic assay for simultaneous determination in serum of the five major antiepileptic drugs(ethosuximide, primidone, phenobarbital,phenytoin,and carbamazepine) and N-desmethylmethsuximide (the compound that must be quantitated for therapeutic drug monitoring of the antiepileptic drug methsuximide). Serum protein is precipitated with an acetone solution containing 5-ethyl-5-(pmethylphenyl)barbituric acid as the internal standard.The centrifuged supernateis injectedontothe chromatographic column. Drugs and internal standard are eluted at 30 #{176}C with mobile phase containing acetonitrile/methanol/ phosphate buffer (17/28/55 by vol) at a flow rate of 0.7 mL/min, monitored at 195 nm. Analysis time is about 20 mm. Quantitation is by measurement of peak areas. Analytical and absolute recoveries varied from 95 to 104%. Within-daycoefficients of variation ranged from 1.6 to 5.4%, between-day CVs from 0.0 to 3.4% in subtherapeutic, therapeutic, and toxic samples. Resolution of therapeutic concentrations of all six drugswas complete.
(HPLC) methods (1-7) for the simultaneous quantitation of the five commonly administered antiepileptic drugs: ethosuximide, primidone, phenobarbital, phenytoin, and carbamazepine (Table 1) . None of these methods was completely evaluated as to accuracy and precision, i.e., determination of relative recovery and within-day and between-day coefficients of variation (CV) for all drugs at subtherapeutic, therapeutic, and toxic concentrations. More importantly, 14 to 85% of the limited results for accuracy and precision reported in published methods (Table 1) were beyond desirable limits. We define "desirable limits" as relative recovery of 95 to 105% and within-day and between-day CVs of 5% or less. Because the concentrations in serum used for reported assessments of accuracy and precision appear to have been selected to give optimal results, the overall accuracy and precision of the methods would (as we found) be even less favorable if evaluated over a full range of the expected concentrations in serum. This failure of published methods to attain desirable limits of accuracy and precision over the full range of serum concentrations makes them unacceptable for research work and less than optimal for routine analysis. Other shortcomings of the available HPLC methods for quantitation of these drugs are listed in Table 1 and discussed below.
There are two published methods for simultaneously determining phenytoin, phenobarbital, primidone, and carbamazepine, but not ethosuximide (8, 9 In addition to the five major antiepileptic drugs, we required the simultaneous determination of N-desmethylmethsuximide. The antiepileptic drug methsuximide is rapidly converted to N-desmethylmethsuximide.
This active metabolite is the only compound present in appreciable quantity in the serum of patients who are under chronic therapy with methsuximide, and it is the compound that must be quantitated for therapeutic drug monitoring of methsuximide therapy (10, 11). There isno published method for the simultaneous determination of the five major antiepileptic drugs and N-desmethylmethsuximide by HPLC. Our objective was to develop a simple, isocratic HPLC method for the simultaneous quantitation of these compounds in serum, with the above-defined desirable limits of accuracy and precision at subtherapeutic, therapeutic, and toxic serum concentrations.
Materials and Methods

Apparatus
The following apparatus from Waters Associates (Milford, MA 01757) was used: Model ALC/CPC 204/6000A HPLC, Model U6K injection system, 3.9 mm X 30 cm "iBondapak C-18" reversed-phasecolumn, and Model 450 variablewavelength detector. Column temperature was controlled by a water circulator (Model FE; Haake Instruments, Saddle Brook, NJ 07662). The recorder was a dual-pen Phosphate buffer. To 1000 mL of de-ionized/redistilled water add 400 iL of 1 mol/L KH2PO4 and adjust to pH 6.0 with 0.9 mol/L phosphoric acid.
Mobile phase. This consists of 170 mL of acetonitrile and 280 mL of methanol in 550 mL of phosphate buffer. The final pH shouldbe 6.8 to 7.0. De-gasthemixturedailyby passing it through a 0.45 im cellulose esterfilter membrane (GN-6 Metricel; Gelman Instruments, Ann Arbor, MI 48106).
Standards
We obtained phenytoin, N-desmethylmethsuximide 
Procedure
To a6 X 50 mm disposable glasstube add 400 zL of serum or plasma and then, with an automatic pipetter-diluter (Model 1500; Syva Co., Palo Alto, CA 94304), add 400 1zLof acetone containing tolylbarb (10 mg/L) as internal standard. Cap the tube, vortex-mix the contents for lOs, centrifuge (4500 to 5000 X g) for 1 mm, transfer the supernate to a similar tube, and centrifuge it for 30s to ensure that no particulate matter will be injected into the chromatograph. Inject 5.0 to 7.5 iL of the supernateinto the chromatograph and elute with mobile (5) phase at 30#{176}C and 0.7 mL/min, monitoring the effluent at 195 nm, at 0.04 A full scale. Figure 1 shows representative chromatograms.
Results and Discussion
Analytical Variables
Mobile phase. Methanol was found necessary for the resolution of carbamazepine in an ambient-temperature analysis. Acetonitrile in the mobile phase reduced detector noise at a wavelength of 195 nm and reduced overall back-pressure. A mobile phase of acetonitrile/methanol/phosphate buffer (17/28/55 by vol) gave optimal resolution of the six antiepileptic drugs under study.
We evaluated the major documented methods involving reversed-phasecolumns eluted with an acetonitrile/phosphate buffer mobile phase (1-5) and found carbamazepine to be less than optimally resolved at low serum concentrations. Column temperature. The temperature used was 30#{176}C to diminish variations in elution volume due to daily changes in ambient temperature. At ambient temperatures there was a slight increase in retention times and back-pressure but no significant lossof peak resolution.
Sample preparation. Sample preparation was a simple protein precipitation described in Materials and Methods (1, 2, 5, 6, 12, 13) . Acetone was used as an extractant because it gave more complete and faster protein precipitation than acetonitrile. Acetone is significantly more ultraviolet-absorptive at 195 nm than acetonitrile. However, no solvent front interferences were observed that would discourage its use.
Method Evaluation
Method of calculation. Five standard solutions were prepared from drug stock standards ranging from subtherapeutic to toxic concentrations. These solutions were taken through the procedure and a linear relationship between drug concentration and peak area was demonstrated. Using a standard solution where the drug concentrations equalled the concentration of the internal standard (10 mg/L), wedivided the area of the internal standard peak by the areas of the drug peaks to establish one set of relative response factors. Additional relative response factors were calculated from areas of subtherapeutic and toxic peaks. An average relative-response factor was determined for each drug.
Quantitation was routinely done by computer, from peakarea ratios of drug to internal standard. The computer measured peak area by determining the total change in ultraviolet absorption within the total retention time as a peak rose and fell to baseline. A peak's total retention time varied slightly (Table 2) . Therefore, all carbamazepine peaks were manually determined, resulting in smaller CVs (Table 2) .
Precision. To drug-free serum samples we added subtherapeutic, therapeutic, andtoxicconcentrations of eachdrug. By replicate analysisof these samples we assessedprecision, both within-day and between-day.These sampleswere also used to confirm linearity of the method (Figure 2) . Within-day CVs varied from 1.5 to 5.4%, between-day CVs from 0.0 to 3.4% (Table 2) .
Accuracy.
We evaluated absoluteand relative analytical recovery.
Exact volumes of pure drug standards containing internal standard were mixed with an equal volume of clean acetone and exactly5 tL wasinjected into the chromatograph. Peak areas for all six drugs and internal standard were measured and recordedat the concentrationsshownin Table 3 . Drugs at concentrationsshownin Table 3 were addedto drug-free serum. An equal volume of drug-supplementedserum was mixed with an equal volume of acetone containing internal (Table 1) . This improved precision and accuracy can be ascribed to the following: (a) better baseline resolution of carbamazepine because of higher ratio of non-polar to polar solvent in mobile phase, (b) better resolution of primidone from ethosuximide becauseof lower operating temperature and slower flow rate, and (c) better resolution of phenobarbital from HPPH because methanol is used in the mobile phase and the pH has been made optimal.
Interferences and background. Our methodology has been in clinical usefor 21 months, and we have processedhundreds of samples from patients on a wide variety of drug regimens. To date, we have found no substance, compound, or metabolite administered in an acute or chronic fashion that interferes with our methodology. Table 4 
